Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

被引:34
作者
Vosnakis, Christos [1 ]
Georgopoulos, Neoklis A. [2 ]
Rousso, David [1 ]
Mavromatidis, Georgios [1 ]
Katsikis, Ilias [3 ]
Roupas, Nikolaos D. [2 ]
Mamali, Irene [2 ]
Panidis, Dimitrios [3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 3, GR-54006 Thessaloniki, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, Patras 26500, Greece
[3] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, GR-54006 Thessaloniki, Greece
关键词
Anti-Mullerian Hormone; LH; insulin resistance; Orlistat; PCOS; INHIBITING SUBSTANCE LEVELS; LUTEINIZING-HORMONE; INSULIN-RESISTANCE; MOUSE OVARY; LEAN WOMEN; OBESITY; GROWTH; ASSOCIATION; GHRELIN; FSH;
D O I
10.3109/09513590.2012.736557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigates the combined effect of diet, physical exercise and Orlistat for 24 weeks, on serum Anti-Mullerian Hormone (AMH) levels in overweight and obese women with polycystic ovary syndrome (PCOS) and in overweight and obese controls. Sixty-one (61) selected women with PCOS and 20 overweight and obese controls followed an energy-restricted diet, physical exercise plus Orlistat administration (120 mg, 3 times per day) for 24 weeks. At baseline, week 12 and week 24, serum levels of AMH, FSH, LH, PRL, androgens, sex hormone-binding globulin (SHBG), glucose, and insulin were measured and Free Androgen Index (FAI) and Insulin Resistance (IR) indices were calculated. In PCOS women, serum AMH levels increased after 12 and 24 weeks of treatment. After 12 weeks LH and SHBG were increased, while Testosterone decreased. After 12 and 24 weeks, FAI was decreased and all indices of IR were significantly improved. We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
[21]   Role of anti-Mullerian hormone in polycystic ovary syndrome [J].
Bhattacharya, Koushik ;
Saha, Ishita ;
Sen, Debanjana ;
Bose, Chaitali ;
Chaudhuri, Gargi Ray ;
Dutta, Sulagna ;
Sengupta, Pallav ;
Bhattacharya, Soumita ;
Barman, Sharit Shekhar ;
Syamal, Alak Kumar .
MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2022, 27 (01)
[22]   Role of anti-Mullerian hormone in polycystic ovary syndrome [J].
Koushik Bhattacharya ;
Ishita Saha ;
Debanjana Sen ;
Chaitali Bose ;
Gargi Ray Chaudhuri ;
Sulagna Dutta ;
Pallav Sengupta ;
Soumita Bhattacharya ;
Sharit Shekhar Barman ;
Alak Kumar Syamal .
Middle East Fertility Society Journal, 27
[23]   Serum Anti-Mullerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms [J].
Ahmed, Nada ;
Batarfi, Asma A. ;
Bajouh, Osama S. ;
Bakhashab, Sherin .
DIAGNOSTICS, 2019, 9 (04)
[24]   Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters [J].
Sumji, Sajad ;
Bhat, Abid ;
Rashid, Aafia ;
Bashir, Rohina ;
Wani, Imtiyaz A. ;
Vasudevan, Vishnu ;
Sehar, Tajali ;
Ganie, Mohd Ashraf .
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2023, 38 (04) :457-465
[25]   The impact of oral contraceptives and metformin on anti-Mullerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia [J].
Panidis, Dimitrios ;
Georgopoulos, Neoklis A. ;
Piouka, Athanasia ;
Katsikis, Ilias ;
Saltamavros, Alexandros D. ;
Decavalas, George ;
Diamanti-Kandarakis, Evanthia .
GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (08) :587-592
[26]   Effects of Raloxifene and their Combination with Pioglitazone on Serum Anti-Mullerian Hormone Levels in Patients with Resistance Polycystic Ovary Syndrome [J].
Kutaif, Rana Hussein ;
Alabbassi, Mustafa G. ;
Hussein, Weqar Akram ;
Aldujaili, Alla Abdul-Mehdi ;
Ali, Zainab Faleh ;
Jassim, Shatha Khayun .
LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (SI) :76-81
[27]   The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome [J].
Sivanandy, Mala S. ;
Ha, Sierra K. .
DIAGNOSTICS, 2023, 13 (05)
[28]   Anti-Mullerian hormone (AMH) as a useful marker in diagnosis of polycystic ovary syndrome [J].
Leonte, Laura ;
Coculescu, M. ;
Radian, S. ;
Fica, Simona ;
Caragheorgheopol, Andra ;
Marinescu, B. ;
Bohaltea, L. C. ;
Grigorescu, F. .
ACTA ENDOCRINOLOGICA-BUCHAREST, 2007, 3 (01) :1-11
[29]   Serum Anti-Mullerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels [J].
Panidis, Dimitrios ;
Katsikis, Ilias ;
Karkanaki, Artemis ;
Piouka, Athanasia ;
Armeni, Anastasia K. ;
Georgopoulos, Neoklis A. .
MEDICAL HYPOTHESES, 2011, 77 (04) :649-653
[30]   Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Mullerian hormone levels [J].
Vagios, Stylianos ;
Sacha, Caitlin R. ;
Hammer, Karissa C. ;
Dimitriadis, Irene ;
James, Kaitlyn E. ;
Bormann, Charles L. ;
Souter, Irene .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2021, 38 (07) :1827-1833